SCHEDULE OF EARNINGS PER SHARE (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Shares used in computation of basic earnings per share for the periods ended			1,442,600	189,700
Total dilutive effect of outstanding stock awards or common stock equivalents			1,714,700	344,000
Shares used in computation of fully diluted earnings per share for the periods ended September 30, 2023 and September 30, 2022, respectively			3,157,300	533,700
Net income (loss)	$ (2,793,670)	$ (2,147,402)	$ (3,610,929)	$ (6,377,731)
Fully diluted income (loss) per share			$ (1.14)	$ (11.95)